S&P 500   4,535.22 (-0.32%)
DOW   35,622.26 (+0.05%)
QQQ   373.50 (-1.00%)
AAPL   149.04 (-0.29%)
MSFT   308.41 (-0.76%)
FB   322.69 (-5.61%)
GOOGL   2,743.34 (-3.33%)
TSLA   902.22 (+0.92%)
AMZN   3,348.00 (-2.53%)
NVDA   226.67 (-0.11%)
BABA   176.78 (-0.36%)
NIO   39.01 (-2.40%)
CGC   13.39 (-4.63%)
GE   103.93 (+0.76%)
AMD   119.51 (+0.15%)
MU   67.50 (-1.66%)
T   25.58 (-0.70%)
F   16.38 (-1.03%)
ACB   7.12 (-3.39%)
DIS   169.03 (-1.35%)
PFE   42.78 (-0.19%)
BA   213.38 (-0.45%)
AMC   36.42 (-7.19%)
S&P 500   4,535.22 (-0.32%)
DOW   35,622.26 (+0.05%)
QQQ   373.50 (-1.00%)
AAPL   149.04 (-0.29%)
MSFT   308.41 (-0.76%)
FB   322.69 (-5.61%)
GOOGL   2,743.34 (-3.33%)
TSLA   902.22 (+0.92%)
AMZN   3,348.00 (-2.53%)
NVDA   226.67 (-0.11%)
BABA   176.78 (-0.36%)
NIO   39.01 (-2.40%)
CGC   13.39 (-4.63%)
GE   103.93 (+0.76%)
AMD   119.51 (+0.15%)
MU   67.50 (-1.66%)
T   25.58 (-0.70%)
F   16.38 (-1.03%)
ACB   7.12 (-3.39%)
DIS   169.03 (-1.35%)
PFE   42.78 (-0.19%)
BA   213.38 (-0.45%)
AMC   36.42 (-7.19%)
S&P 500   4,535.22 (-0.32%)
DOW   35,622.26 (+0.05%)
QQQ   373.50 (-1.00%)
AAPL   149.04 (-0.29%)
MSFT   308.41 (-0.76%)
FB   322.69 (-5.61%)
GOOGL   2,743.34 (-3.33%)
TSLA   902.22 (+0.92%)
AMZN   3,348.00 (-2.53%)
NVDA   226.67 (-0.11%)
BABA   176.78 (-0.36%)
NIO   39.01 (-2.40%)
CGC   13.39 (-4.63%)
GE   103.93 (+0.76%)
AMD   119.51 (+0.15%)
MU   67.50 (-1.66%)
T   25.58 (-0.70%)
F   16.38 (-1.03%)
ACB   7.12 (-3.39%)
DIS   169.03 (-1.35%)
PFE   42.78 (-0.19%)
BA   213.38 (-0.45%)
AMC   36.42 (-7.19%)
S&P 500   4,535.22 (-0.32%)
DOW   35,622.26 (+0.05%)
QQQ   373.50 (-1.00%)
AAPL   149.04 (-0.29%)
MSFT   308.41 (-0.76%)
FB   322.69 (-5.61%)
GOOGL   2,743.34 (-3.33%)
TSLA   902.22 (+0.92%)
AMZN   3,348.00 (-2.53%)
NVDA   226.67 (-0.11%)
BABA   176.78 (-0.36%)
NIO   39.01 (-2.40%)
CGC   13.39 (-4.63%)
GE   103.93 (+0.76%)
AMD   119.51 (+0.15%)
MU   67.50 (-1.66%)
T   25.58 (-0.70%)
F   16.38 (-1.03%)
ACB   7.12 (-3.39%)
DIS   169.03 (-1.35%)
PFE   42.78 (-0.19%)
BA   213.38 (-0.45%)
AMC   36.42 (-7.19%)
OTCMKTS:BLUSF

BELLUS Health Stock Forecast, Price & News

$6.09
+0.03 (+0.50 %)
(As of 10/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.96
▼
$6.09
50-Day Range
$2.04
▼
$6.64
52-Week Range
$0.49
▼
$2.60
Volume383,629 shs
Average Volume39,610 shs
Market Capitalization$969.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive BLUSF News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.


BELLUS Health logo

About BELLUS Health

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Headlines

BELLUS Health (OTCMKTS:BLUSF) Reaches New 1-Year High at $6.42
October 19, 2021 |  americanbankingnews.com
BELLUS Health (OTCMKTS:BLUSF) Reaches New 52-Week High at $6.39
October 14, 2021 |  americanbankingnews.com
BELLUS Health (OTCMKTS:BLUSF) Hits New 1-Year High at $6.20
October 4, 2021 |  americanbankingnews.com
BELLUS Health (OTCMKTS:BLUSF) Sets New 1-Year High at $6.64
September 27, 2021 |  americanbankingnews.com
What's Going On With BELLUS Health's Stock Today?
September 13, 2021 |  benzinga.com
BELLUS Health Inc (BLU) Investor Presentation - Slideshow
September 15, 2020 |  seekingalpha.com
Bellus Health Inc (BLUSF) Option Chain
November 7, 2019 |  www.nasdaq.com
Bellus Health to reverse split shares 1:3.6
August 15, 2019 |  seekingalpha.com
BELLUS Health (BLUSF) Presents At Raymond James Life Sciences & MedTech Conference - Slideshow
June 20, 2019 |  seekingalpha.com
BELLUS Health (BLUSF) Presents At Jefferies 2019 Healthcare Conference - Slideshow
June 7, 2019 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BLUSF
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.bellushealth.com
Phone
45-0680-4500
Employees
10
Year Founded
N/A

Sales & Book Value

Annual Sales
$30,000.00
Price / Sales
32,300.75
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
24.36

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
$-7.01 million
Net Margins
-49,910.34%
Return on Equity
-48.37%
Return on Assets
-45.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.87
Quick Ratio
13.87

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
159,117,000
Market Cap
$969.02 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












BELLUS Health (OTCMKTS:BLUSF) Frequently Asked Questions

What stocks does MarketBeat like better than BELLUS Health?

Wall Street analysts have given BELLUS Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BELLUS Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were BELLUS Health's earnings last quarter?

BELLUS Health Inc (OTCMKTS:BLUSF) released its earnings results on Wednesday, May, 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.01. The business earned $0.01 million during the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%.
View BELLUS Health's earnings history.

Who are BELLUS Health's key executives?

BELLUS Health's management team includes the following people:
  • Roberto Bellini, President, Chief Executive Officer & Director
  • François Desjardins, Vice President-Finance
  • Denis Garceau, Senior Vice President-Drug Development
  • Tony Matzouranis, Vice President-Business Development
  • Sébastien Roy, Secretary

What is BELLUS Health's stock symbol?

BELLUS Health trades on the OTCMKTS under the ticker symbol "BLUSF."

How do I buy shares of BELLUS Health?

Shares of BLUSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BELLUS Health's stock price today?

One share of BLUSF stock can currently be purchased for approximately $6.09.

How much money does BELLUS Health make?

BELLUS Health has a market capitalization of $969.02 million and generates $30,000.00 in revenue each year.

How many employees does BELLUS Health have?

BELLUS Health employs 10 workers across the globe.

What is BELLUS Health's official website?

The official website for BELLUS Health is www.bellushealth.com.

Where are BELLUS Health's headquarters?

BELLUS Health is headquartered at 275 ARMAND-FRAPPIER BLVD., LAVAL A8, H7V 4A7.

How can I contact BELLUS Health?

BELLUS Health's mailing address is 275 ARMAND-FRAPPIER BLVD., LAVAL A8, H7V 4A7. The company can be reached via phone at 45-0680-4500 or via email at [email protected].


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.